Company Email Format Management

Vicore Pharma AB

Pharmaceutical Manufacturing Stockholm, Stockholms Län, Se 46 employees STOCK

Employees: 46
Contacts: 2
Emails: 2
Phones: 1

vicorepharma.com LinkedIn Crunchbase

Vicore Pharma AB Overview

Headquarters: Stockholm, Stockholms Län, Se
Phone Number: Available in AeroLeads
Website: vicorepharma.com
Industry: Pharmaceutical Manufacturing
Employees: 46
Founded: 2009
Stock Symbol: STOCK
Funding: 10.0M
Company Email: Available in AeroLeads
NAICS: Pharmaceutical and Medicine Manufacturing

Medicinal and Botanical Manufacturing

Pharmaceutical Preparation Manufacturing

Keywords

pharmaceutical development

About Vicore Pharma AB

Vicore is an innovative clinical-stage pharmaceutical company unlocking the potential of a new class of drugs with disease-modifying potential. The company is establishing a portfolio in respiratory diseases, including idiopathic pulmonary fibrosis (IPF). Buloxibutid (C21) is a first-in-class orally available small molecule angiotensin II type 2 receptor agonist (ATRAG) currently in phase 2a development for IPF. Almee™ (an investigational medical device in clinical development) is a digital therapeutic based on cognitive behavioral therapy created to address the psychological impact of living with pulmonary fibrosis. Almee has received Breakthrough Device Designation from the FDA, reflecting its potential to have transformative impact. Using its unique expertise in ATRAG chemistry and biology, Vicore is further fueling its pipeline with several new therapies across additional potential indications. The company’s shares (VICO) are listed on Nasdaq Stockholm’s main market. For more information, see www.vicorepharma.com.